Article de revue
Population access to new vaccines in European countries
Time from registration to population access to new vaccines can take considerable time in European countries. Reasons might be found in the regulatory framework, decision-making processes or the assessment of vaccines by evaluating bodies. The aim of this study was to determine whether some decision-making processes can explain between-country differences in the time to population access to new vaccination programs.
Auteurs
Langues
- Anglais
Année de publication
2013
Journal
Vaccine
Volume
31
Numéro
27
Type
Article de revue
Catégories
- Gestion de programme
Pays
- Europe
Mots-clés
- Introduction de nouveaux vaccins
Régions de l'OMS
- Région européenne
